Filed: 8/14/2026ACC: 0001013594-26-000908
📋 What this filing means
LION POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $20.91M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$20.91M
Total AUM (reported)
3.60M
Total Shares
Allocation by class
COM$13.34M63.8%
COM NEW$2.82M13.5%
CLASS A ORD$1.31M6.3%
SPONSORED ADS$1.28M6.1%
SHS CLASS A$1.20M5.7%
SHS$677.1K3.2%
ORDINARY SHARES$274.2K1.3%
Portfolio Concentration
Top 3$4.47M21.4%
4–10$7.03M33.6%
11–25$7.34M35.1%
Rest$2.07M9.9%
Top 3 weight
21.4%
Top 10 weight
55.0%
Voting Authority Distribution
Total shares with voting rights: 3.60M
Sole
Full voting authority
3.60M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
CUE BIOPHARMA INC
SOLEShares52.93K
TypeSH
Market value$1.67M
7.99%
Sole
52.93K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares4.45K
TypeSH
Market value$1.49M
7.13%
Sole
4.45K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares67.50K
TypeSH
Market value$1.31M
6.29%
Sole
67.50K
Shared
0.00
None
0.00
FENNEC PHARMACEUTICALS INC
SOLEShares112.43K
TypeSH
Market value$1.21M
5.78%
Sole
112.43K
Shared
0.00
None
0.00
ROYALTY PHARMA PLC
SOLEShares21.40K
TypeSH
Market value$1.20M
5.74%
Sole
21.40K
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares80K
TypeSH
Market value$1.13M
5.41%
Sole
80K
Shared
0.00
None
0.00
MILESTONE PHARMACEUTICALS IN
SOLEShares820K
TypeSH
Market value$1.10M
5.26%
Sole
820K
Shared
0.00
None
0.00
BENITEC BIOPHARMA INC
SOLEShares62K
TypeSH
Market value$829.6K
3.97%
Sole
62K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares36K
TypeSH
Market value$787.0K
3.76%
Sole
36K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares51.70K
TypeSH
Market value$769.3K
3.68%
Sole
51.70K
Shared
0.00
None
0.00
GERON CORP
SOLEShares578K
TypeSH
Market value$739.8K
3.54%
Sole
578K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares14.70K
TypeSH
Market value$677.1K
3.24%
Sole
14.70K
Shared
0.00
None
0.00
ARDELYX INC
SOLEShares128.65K
TypeSH
Market value$656.1K
3.14%
Sole
128.65K
Shared
0.00
None
0.00
LANTHEUS HLDGS INC
SOLEShares5.50K
TypeSH
Market value$610.2K
2.92%
Sole
5.50K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares8.10K
TypeSH
Market value$592.4K
2.83%
Sole
8.10K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares28.50K
TypeSH
Market value$512.1K
2.45%
Sole
28.50K
Shared
0.00
None
0.00
HUMACYTE INC
SOLEShares650K
TypeSH
Market value$507.3K
2.43%
Sole
650K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares46K
TypeSH
Market value$504.6K
2.41%
Sole
46K
Shared
0.00
None
0.00
VIATRIS INC
SOLEShares27.70K
TypeSH
Market value$439.9K
2.10%
Sole
27.70K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares18K
TypeSH
Market value$399.8K
1.91%
Sole
18K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares5K
TypeSH
Market value$372.4K
1.78%
Sole
5K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares9.10K
TypeSH
Market value$369.7K
1.77%
Sole
9.10K
Shared
0.00
None
0.00
PACIRA BIOSCIENCES INC
SOLEShares13.50K
TypeSH
Market value$342.5K
1.64%
Sole
13.50K
Shared
0.00
None
0.00
REGENXBIO INC
SOLEShares26.60K
TypeSH
Market value$318.7K
1.52%
Sole
26.60K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares86K
TypeSH
Market value$294.1K
1.41%
Sole
86K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CUE BIOPHARMA INCSOLE | COM | 52.93K | SH | $1.67M 7.99% | 52.93K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 4.45K | SH | $1.49M 7.13% | 4.45K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 67.50K | SH | $1.31M 6.29% | 67.50K | 0.00 | 0.00 |
FENNEC PHARMACEUTICALS INCSOLE | COM | 112.43K | SH | $1.21M 5.78% | 112.43K | 0.00 | 0.00 |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 21.40K | SH | $1.20M 5.74% | 21.40K | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | SPONSORED ADS | 80K | SH | $1.13M 5.41% | 80K | 0.00 | 0.00 |
MILESTONE PHARMACEUTICALS INSOLE | COM | 820K | SH | $1.10M 5.26% | 820K | 0.00 | 0.00 |
BENITEC BIOPHARMA INCSOLE | COM NEW | 62K | SH | $829.6K 3.97% | 62K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 36K | SH | $787.0K 3.76% | 36K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 51.70K | SH | $769.3K 3.68% | 51.70K | 0.00 | 0.00 |
GERON CORPSOLE | COM | 578K | SH | $739.8K 3.54% | 578K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 14.70K | SH | $677.1K 3.24% | 14.70K | 0.00 | 0.00 |
ARDELYX INCSOLE | COM | 128.65K | SH | $656.1K 3.14% | 128.65K | 0.00 | 0.00 |
LANTHEUS HLDGS INCSOLE | COM | 5.50K | SH | $610.2K 2.92% | 5.50K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 8.10K | SH | $592.4K 2.83% | 8.10K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 28.50K | SH | $512.1K 2.45% | 28.50K | 0.00 | 0.00 |
HUMACYTE INCSOLE | COM | 650K | SH | $507.3K 2.43% | 650K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 46K | SH | $504.6K 2.41% | 46K | 0.00 | 0.00 |
VIATRIS INCSOLE | COM | 27.70K | SH | $439.9K 2.10% | 27.70K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 18K | SH | $399.8K 1.91% | 18K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 5K | SH | $372.4K 1.78% | 5K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 9.10K | SH | $369.7K 1.77% | 9.10K | 0.00 | 0.00 |
PACIRA BIOSCIENCES INCSOLE | COM | 13.50K | SH | $342.5K 1.64% | 13.50K | 0.00 | 0.00 |
REGENXBIO INCSOLE | COM | 26.60K | SH | $318.7K 1.52% | 26.60K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 86K | SH | $294.1K 1.41% | 86K | 0.00 | 0.00 |
Page 1 of 2